It was shown that FOXO1 presented a decreasing trend at the mRNA and protein levels in clinical (Fig. 4A, D ) and mice (Fig. 4B, E ) liver samples, and the same decreased trend was observed in hepatic lymphocytes (Fig. 4C, F ).
← all excerpts
FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury.
1
—
—